Cookievoorkeuren

Wij hechten veel waarde aan uw privacy, daarom informeren wij u over cookies op onze website.

In deze pop-up kunt u uw voorkeuren met betrekking tot cookies instellen. Een overzicht van alle cookies bekijkt u op onze cookies pagina. In onze privacyverklaring leest u hoe we uw persoonsgegevens verwerken.

Als u op akkoord klikt, dan geeft u toestemming op alle functionele, analyse en trackingcookies. Wij gebruiken deze gegevens voor het optimaliseren van de website. Mocht u dit niet willen, kunt u op de knop “Instellingen” klikken. Hier kunt u de cookievoorkeuren instellen.

InstellingenIk ga akkoord

Nieuws

aug
13

European Foundation for the Study of Diabetes - new funding opportunities (€ 300,000)

The European Foundation for the Study of Diabetes (EFSD) has published new funding opportunities for this year. Deadlines are in September, October and November. In most cases, grants are up to € 100,000. EFSD offers support in all areas of diabetes research through a wide range of joint initiatives and stand-alone initiatives. Funding is available throughout the year.

The available calls are for the following:

EFSD/Lilly European Diabetes Research Programme: grants are each of up to € 100,000. The duration of each award may be one year or longer, depending upon the needs of the project and as justified in the application. Deadline of submission is September 1, 2015;
EFSD/Sanofi European Research Programme: Innovative Approaches for the Treatment of Type 1 and Type 2 Diabetes: grants are each of up to € 100,000. The duration of the award may be one year or longer, depending upon the needs of the project and as justified in the application. Deadline of submission is October 15, 2015;
EFSD European Diabetes Research Programme in Cellular Plasticity Underlying the Pathophysiology of Type 2 Diabetes supported by a research grant from AstraZeneca: grants are each of up to € 100,000. The duration of the award may be one year or longer, depending upon the needs of the project and as justified in the application. Deadline of submission is November 1, 2015;
EFSD Clinical Diabetes Research Programme in Macrovascular Complications of Diabetes supported by a research grant from AstraZeneca: grants are each of up to € 300,000. The duration of the award may be up to three years, depending upon the needs of the project and as justified in the application. Deadline of submission is November 1, 2015;
Available throughout the year: Albert Renold Travel Fellowships supported by Merck Sharp & Dohme (MSD): Each Fellowship will be for up to € 8,000.

For further information on these and future programmes of EFSD check the RFAs and closing dates website of the EFSD.

Terug naar overzicht